Cyrus Biotechnology logo

Cyrus Biotechnology

cyrusbio.com

Cyrus Biotechnology develops computationally engineered biologics from natural proteins for therapeutic applications, with lead programs targeting severe autoimmune diseases and acute respiratory distress syndrome. The company uses protein design algorithms and laboratory methods to create novel variants and fusion proteins, aiming to provide superior efficacy and address unmet medical needs.

Facts

HQ
Seattle, Washington, US
Sectors
Biotechnology Research
Founded
2014
Type
Corporation Seattle business license
Employees
17
Registered name
Cyrus Biotechnology Inc Seattle business license
Stage
Series B
Members see funding amounts.
.
Founders
David Baker

Is this your organization? Claim it

Early Pre-seed Angel Investing DD in Medical bioscience startups

Some of the companies are medical companies where people are having a questions about how you might evaluate a medical company. We have invited Eric Larsen to talk about his approach to evaluating a medical company. Eric Larsen serves as Board Chairman, Innovative Fund Administrator & Life Science Committee Chair at Alliance of Angels. He also serves as Board Observer at Cyrus Biotechnology. He is also a Founding Investor at Pack Ventures. He was a Co-Founder and served as Chief Executive Officer & Chairman at SiDx.

People

  • Lucas Nivon
    Lucas Nivon Executive Officer, Director, Co-Founder and Chief Executive Officer
  • Yifan Song Director, Co-founder and Chief Technology Officer
  • Erik Procko Executive, Chief Scientific Officer

Online